The use of oral glucocorticoids and the risk of major osteoporotic fracture in patients with myasthenia gravis

被引：0
|
作者：
Zohreh Safipour
Rogier van der Zanden
Joop van den Bergh
Paddy Janssen
Peter Vestergaard
Frank de Vries
Johanna H. M. Driessen
机构：
[1] Curaçao Medical Centre,Department of Clinical Pharmacy
[2] Maastricht University Medical Centre,Department of Clinical Pharmacy
[3] Maastricht University Medical Centre,Department of Internal Medicine
[4] Hasselt University,Faculty of Medicine and Life Science
[5] Viecuri Medical Centre,Department of Internal Medicine
[6] Viecuri Medical Centre,Department of Clinical Pharmacy
[7] Aalborg University Hospital,Departments of Clinical Medicines and Endocrinology
[8] Steno Diabetes Center North Jutland,MRC Lifecourse Epidemiology Unit
[9] Southampton General Hospital,Division of Pharmacoepidemiology and Clinical Pharmacology
[10] Utrecht Institute of Pharmaceutical Sciences,NUTRIM
[11] Cardiovascular Research Institute Maastricht (CARIM),School for Nutrition and Translational Research in Metabolism
[12] Maastricht University,undefined
来源：
Osteoporosis International | 2022年 / 33卷
关键词：
Glucocorticoids; Fracture; Bone; Myasthenia gravis; Case–control study;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：649 / 658
页数：9
相关论文
共 50 条
  • [31] RISK BENEFIT ANALYSIS OF TREATMENTS FOR PATIENTS WITH MYASTHENIA GRAVIS
    Qi, Cynthia
    Hughes, Tom
    Wang, Jessie
    Yang, Hongbo
    Gelinas, Deborah
    Smith, A. Gordon
    Habib, Ali
    Brauer, Eddie
    Du, Mandy
    Sun, Rochelle
    Phillips, Glenn
    MUSCLE & NERVE, 2022, 66 : S135 - S135
  • [32] Risk of Infection in Patients with Myasthenia Gravis With and Without Thymoma
    Clifford, Katherine
    McKeen, Will
    Yuan, Ye
    Muppidi, Srikanth
    NEUROLOGY, 2023, 100 (17)
  • [33] Fracture rate in patients with myasthenia gravis: the general practice research database
    Pouwels, S.
    de Boer, A.
    Javaid, M. K.
    Hilton-Jones, D.
    Verschuuren, J.
    Cooper, C.
    Leufkens, H. G.
    de Vries, F.
    OSTEOPOROSIS INTERNATIONAL, 2013, 24 (02) : 467 - 476
  • [34] Individual fracture risk and the cost-effectiveness of bisphosphonates in patients using oral glucocorticoids
    van Staa, T. P.
    Geusens, P.
    Zhang, B.
    Leufkens, H. G. M.
    Boonen, A.
    Cooper, C.
    RHEUMATOLOGY, 2007, 46 (03) : 460 - 466
  • [35] Fracture rate in patients with myasthenia gravis: the general practice research database
    S. Pouwels
    A. de Boer
    M. K. Javaid
    D. Hilton-Jones
    J. Verschuuren
    C. Cooper
    H. G. Leufkens
    F. de Vries
    Osteoporosis International, 2013, 24 : 467 - 476
  • [36] Minor fractures increase the risk of major subsequent osteoporotic fracture
    不详
    Nature Clinical Practice Endocrinology & Metabolism, 2007, 3 (5): : 381 - 382
  • [37] CUMULATIVE RISKS OF FRACTURE IN PATIENTS USING ORAL GLUCOCORTICOIDS
    Van Staa, Tjeerd P.
    Geusens, Piet
    Pols, Huib
    De Laet, Chris
    Leufkens, Hubert G. M.
    Cooper, Cyrus
    CALCIFIED TISSUE INTERNATIONAL, 2004, 74 : S32 - S33
  • [38] Cumulative risks of fracture in patients using oral glucocorticoids
    van Staa, TP
    Geusens, P
    Pols, H
    de Laet, C
    Leufkens, HGM
    Cooper, C
    JOURNAL OF BONE AND MINERAL RESEARCH, 2003, 18 : S21 - S21
  • [39] Tacrolimus in refractory patients with myasthenia gravis: Coadministration and tapering of oral prednisolone
    Shimojima, Y
    Matsuda, M
    Gono, T
    Ishii, W
    Tokuda, T
    Ikeda, S
    JOURNAL OF CLINICAL NEUROSCIENCE, 2006, 13 (01) : 39 - 44
  • [40] The risk of extrathymic malignancies in thymoma patients with and without myasthenia gravis
    Owe, J. F.
    Smaastuen, M. C.
    Romi, F.
    Gilhus, N. E.
    EUROPEAN JOURNAL OF NEUROLOGY, 2008, 15 : 150 - 150
12345